Life Science REIT IPO aims to raise £300m after lining up £445m investment pipeline

Ironstone Asset Management named investment adviser

clock • 2 min read
Will be the first London-listed REIT focused on UK life science properties

Will be the first London-listed REIT focused on UK life science properties

Life Science REIT will target a £300m raise when it floats on the AIM market of the London Stock Exchange next month, becoming the first London-listed real estate investment trust (REIT) focused on UK life science properties, with a £445m pipeline of projects.

The company will launch an IPO on AIM by way of a placing, offer for subscription and intermediaries offer, targeting the issue of 300 million ordinary shares of £0.01 each in the capital of the company, at an issue price of 100p per share, with admission expected in mid-November. Ironstone Asset Management has been appointed its investment adviser, with a management team led by Simon Farnsworth, some of the members of which have committed to invest around £3m in the issue. BMO postpones REIT IPO as sector challenges cause volatility Investors in Life Science REIT will have exposur...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week